LT - COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER
EN - COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/704 |
(2006.01) |
|
|
A61K 45/06 |
(2013.01) |
|
|
A61K 31/702 |
(2006.01) |
|
|
A61K 31/704 |
(2013.01) |
|
|
A61K 31/573 |
(2006.01) |
|
|
A61P 35/00 |
(2018.01) |
|
|
A61K 39/395 |
(2006.01) |
|
|
A61K 39/3955 |
(2013.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
C07K 16/2818 |
(2013.01) |
|
|
A61K2039/505 |
(2013.01) |
|
|
C07K2317/76 |
(2013.01) |
European patent
| (11) |
Number of the document |
3554511 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
17880962.0 |
|
Date of filing the European patent application |
2017-12-15 |
| (97) |
Date of publication of the European application |
2019-10-23 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-07-10
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/AU2017/051402 |
|
Date |
2017-12-15 |
PCT application publication
| (87) |
Number |
WO 2018/107244 |
|
Date |
2018-06-21 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
2016905199 |
2016-12-15
|
AU |
Inventors
| (72) |
DREDGE, Keith , AU
|
Grantee
| (73) |
Progen PG500 Series Pty Ltd ,
184 Moorabool Street, Geelong, Victoria 3220,
AU
|
Title
| (54) |
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER |
| |
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER |
